Literature DB >> 11073267

Molecular mechanisms of secondary hyperparathyroidism.

J Silver1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11073267     DOI： 10.1093/ndt/15.suppl_5.2

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

Review 1.  FGF23 in skeletal modeling and remodeling.

Authors:  Yongbo Lu; Jian Q Feng
Journal:  Curr Osteoporos Rep       Date:  2011-06       Impact factor: 5.096

Review 2.  FGF23 associated bone diseases.

Authors:  Eryuan Liao
Journal:  Front Med       Date:  2013-03-09       Impact factor: 4.592

3.  Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23.

Authors:  S DeLuca; D Sitara; K Kang; R Marsell; K Jonsson; T Taguchi; R G Erben; M S Razzaque; B Lanske
Journal:  J Pathol       Date:  2008-11       Impact factor: 7.996

Review 4.  Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy.

Authors:  Claudia Friedl; Emanuel Zitt
Journal:  Drug Des Devel Ther       Date:  2018-06-01       Impact factor: 4.162

Review 5.  PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond.

Authors:  Ignacio Portales-Castillo; Petra Simic
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.